News coverage about Varian Medical Systems (NYSE:VAR) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave media stories about the medical equipment provider an impact score of 46.0056878150596 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of Varian Medical Systems (NYSE VAR) opened at $125.49 on Wednesday. Varian Medical Systems has a one year low of $87.49 and a one year high of $130.29. The firm has a market cap of $11,554.05, a price-to-earnings ratio of 31.02, a P/E/G ratio of 3.67 and a beta of 0.85.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.06. The business had revenue of $678.50 million for the quarter, compared to analysts’ expectations of $633.96 million. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The business’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.09 earnings per share. equities analysts anticipate that Varian Medical Systems will post 4.31 earnings per share for the current fiscal year.

Several analysts have issued reports on VAR shares. Citigroup lifted their target price on Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research report on Thursday, January 25th. Zacks Investment Research raised Varian Medical Systems from a “hold” rating to a “buy” rating and set a $142.00 target price on the stock in a research report on Tuesday. ValuEngine upgraded Varian Medical Systems from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. TheStreet cut Varian Medical Systems from a “b+” rating to a “c” rating in a report on Monday, February 12th. Finally, BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a report on Sunday, January 28th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $111.80.

In related news, Director Timothy E. Guertin sold 10,000 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total value of $1,114,600.00. Following the sale, the director now owns 2,161 shares in the company, valued at approximately $240,865.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP John W. Kuo sold 7,991 shares of the company’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $110.65, for a total transaction of $884,204.15. Following the completion of the sale, the senior vice president now owns 27,363 shares in the company, valued at approximately $3,027,715.95. The disclosure for this sale can be found here. Insiders have sold a total of 188,006 shares of company stock worth $21,706,262 in the last three months. Insiders own 0.78% of the company’s stock.

WARNING: This report was posted by Marea Informative and is the property of of Marea Informative. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.mareainformativa.com/2018/03/14/varian-medical-systems-var-receiving-somewhat-favorable-news-coverage-report-finds-updated-updated-updated.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.